Related Experiment Video
Updated: Jun 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing
Sara M Fitzgerald-Butt1, Lindsey Byrne, Cynthia A Gerhardt
1Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. sara.fitzgerald-butt@nationwidechildrens.org
Parental interest in genetic testing for hypertrophic cardiomyopathy (HCM) is influenced by knowledge and views. Understanding these factors can improve clinical care for children with HCM.
Area of Science:
- Genetics
- Cardiology
- Pediatrics
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent autosomal dominant disorder associated with sudden cardiac death risk.
- Clinical genetic testing for HCM is underutilized despite its diagnostic and predictive value.
Purpose of the Study:
- To assess parental interest in genetic testing for hypertrophic cardiomyopathy (HCM) in children.
- To identify determinants influencing caregivers' decisions regarding genetic testing for HCM.
Main Methods:
- A questionnaire was developed and administered to 30 adult caregivers of pediatric HCM patients.
- Logistic regression analysis was used to identify predictors of interest in genetic testing.
Main Results:
- While 80% of participants knew about genetic testing generally, only 30% were aware of HCM-specific genetic testing.
- 62% expressed interest in future genetic testing for their child, with 28% considering it within a year.
- Younger age, higher education, knowledge of carrier testing, positive views on genetics, and awareness of HCM heritability predicted interest.
Conclusions:
- Caregiver knowledge and perceptions significantly impact the consideration of genetic testing for pediatric HCM.
- Healthcare providers can use this framework to enhance understanding and encourage appropriate genetic testing, improving clinical management for pediatric HCM patients.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cardiomyopathy V: Interprofessional Care
Pedigree Analysis
Pedigree Analysis